50-day free link to our work here - ➡️ authors.elsevier.com/c/1j02A5EIIgPd… The Lancet Oncology #radonc #kcsm. Peter Mac Radiation Oncology Sandro Porceddu

II WORKSHOP IMMUNO-HUB IMMUNOTERAPIA: Cura e prevenzione di malattie infettive e tumorali Due giornate per confrontarsi sul ruolo dell’immunoterapia nella terapia e nella prevenzione delle malattie tumorali e infettive. È quanto accade oggi e domani 16 e 17 maggio all’Istituto

II Workshop Immunohub: Care and Prevention of tumoral and infective disease Istituto Tumori #immunohub #ministerodellasalute #traiettoria4 #clinicalresearch

#clinicalresearch #prostatecancer #genitourinarydisease

Updated 📢#RenalCellCarcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Assessing mature data for first-line metastatic trials as well as sequencing strategies & new agents such as belzutifan. ow.ly/nZA050RP77l #kcsm @silke_gillessen

💫📢 Hot from the oven 🔥 Here is the latest version of ESMO - Eur. Oncology renal cell carcinoma guideline✅ Tom Powles Laurence Albiges Viktor Grünwald Ravindran Kanesvaran Rana McKay, MD, FASCO silke gillessen OncoAlert Toni Choueiri, MD Yüksel Ürün Dana-Farber Lank Center for Genitourinary Oncology KidneyCAN esmo.org/guidelines/gui…

Si è conclusa oggi una bellissima riunione del gruppo Meet-URO, occasione per interessante confrontoi scientifico e per incontrare tanti amici e colleghi. Un grazie speciale a Sandro pignata e a Marilena Di Napoli per il programma e per l'organizzazione nella splendida Paestum

Meet the #CCE Partners 💥 This week, we're introducing you to Istituto Tumori, a leading cancer facility in Italy and Europe. In addition, it serves as a national and regional referral center and hub for the majority of common and rare cancers. Learn more ➡️ rb.gy/t9fi3z

Thank you Dena Battle KCCure for this impt contribution! Will be citing your data, along with key contributions to the field of non-clear cell RCC from Toni Choueiri, MD Tom Powles Cris Stéphane Oudard Pavlos Msaouel Laurence Albiges Bradley McGregor Giuseppe Procopio Rana McKay, MD, FASCO & so many

🇮🇹🇮🇹😌

Si apre l’evento a Milano in Fondazione Feltrinelli What's NU - Traguardi che ispirano il futuro, con un Expert Talk di altissimo livello: il Prof. Giuseppe Procopio modera la discussione tra i Professori Gero Kramer e Karim Fizazi. Giuseppe Procopio overgroup.eu/evento/whats-n…

🗓️ 20/06/2024 🏥 Aula Magna "G. Bonadonna" Fondazione IRCCS Istituto Nazionale dei Tumori ⚕️ Giornata della Ricerca 2024: focus sulla cancer research nel contesto europeo. Non perderti gli interventi di esperti e le ultime novità nella lotta contro il cancro.

More info here: authors.elsevier.com/sd/article/S20… #CancerResearch #oncology #ProstateCancer

📰 Updated IF for Oncology/Hematology journals

Positive results from the NIAGARA Phase III trial showed durvalumab with neoadjuvant chemo then cystectomy had a statistically significant and clinically meaningful improvement in EFS & OS versus chemo/cystectomy alone in muscle invasive bladder cancer astrazeneca.com/media-centre/p…

📣 SAVE THE DATE XIV^ Riunione Nazionale Meet-URO 🗓️Firenze, 22-23 MAGGIO 2025 Giuseppe Procopio

Full article here: doi.org/10.1016/j.clgc… #cancerresearch #genitourinary #renalcarcinoma

10/ Our work represents an important step towards better understanding and managing recurrent RCC following adjuvant IO. We hope that future research with larger number of patients and longer follow-up can build on these findings by investigating novel biomarkers to improve

Congrats Talal El Zarif, MD Karl Semaan, MD, MSc and all IMDC team for this work in European Urology ! Dana-Farber Lank Center for Genitourinary Oncology albertacancer Smilow Cancer Hospital OncoAlert

Full article here: kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2… #CancerResearch #Oncology #RareGenitourinaryTumors